CA-INSEEGO-CORP
9.2.2021 15:02:10 CET | Business Wire | Press release
Inseego Corp. (Nasdaq: INSG), a leader in 5G and intelligent IoT device-to-cloud solutions, today announced that its new Wavemaker PRO 5G indoor router has been certified for use in Europe, North America* and Australia, with additional regulatory certifications pending for other international markets. Designed specifically for enterprise customers, this router combines high-performance, multi-carrier 5G and Wi-Fi 6 connectivity with cloud software that simplifies device management, maximizes security and minimizes expenses for enterprise users.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210209005447/en/
“Our Wavemaker PRO 5G solutions are changing the way enterprise and SMB customers think about broadband access,” said Inseego President Ashish Sharma. “Whether they have remote branch offices needing faster primary communications, retail locations needing failover solutions, or a distributed workforce needing dependable and secure work-from-home access to their corporate network, the FG2000e router can deliver unmatched speed, throughput and reliability — along with software solutions that make it easy for IT organizations to deploy and manage their devices, protect their networks, and reap the benefits of a multi-carrier 5G managed WAN.”
Bringing 5G enterprise solutions to global markets
The Wavemaker PRO 5G indoor router FG2000e has now received industry certifications that make it commercially available for deployments in many global markets. It’s important to understand that different countries and regions require different types of regulatory and 3GPP certifications in order to operate 5G products on mobile networks. For example, GCF certification demonstrates that products conform with 3GPP standards and will be interoperable with mobile networks worldwide. CE certification means that solutions can be sold to service providers and enterprise customers in over 30 countries of the European Economic Area (EEA) and European Free Trade Association (EFTA). RCM certification verifies that electrical and wireless equipment can be sold in Australia. And FCC certification requires a rigorous process of testing before RF products can be sold and marketed in the U.S.
Having completed all of these certifications, the FG2000e router can now be sold to service providers and enterprise customers across all of these regions, including organizations that are deploying 5G private networks.
New global channel partners
In addition to partnering with service providers, Inseego is expanding its network of distributors, resellers and system integrators worldwide to create new channels to market, along with local market support for its new enterprise solutions. The FG2000e router and software provides local language support, including English, French, Italian, Spanish, German, Arabic and Japanese.
A multi-carrier 5G cloud managed WAN for ubiquitous broadband connectivity
The Wavemaker PRO 5G indoor router FG2000e provides high-performance 5G connectivity and 4G LTE fallback, with features such as:
- Unlocked, dual-SIM, multi-carrier firmware that provides flexibility and ultimate control of the network the router connects to, avoiding downtime and data usage overage charges
- Centralized cloud management through the Inseego Manage ™ cloud solution, which simplifies device configuration, installation, remote management, security and support, providing an excellent customer experience right “out of the box” and for the full product lifecycle
- Enterprise-grade security that includes WPA3 Wi-Fi security support, advanced encryption, Open VPN and IPsec VPN
- Added value with a robust pipeline of new features including WAN management, enterprise security, device management and vertical market applications.
The Wavemaker PRO 5G indoor router FG2000e can deliver gigabit-plus speeds (using sub-6 GHz 5G) that match or outperform typical cable and fiber optic speeds. The FG2000e is ideal for business offices, retail locations, medical facilities, campuses and remote job sites needing reliable, high-speed broadband access with features such as:
- A 5 Gbps ethernet port, additional LAN and WAN ports, and TS9 port for external antenna
- Wi-Fi 6 technology to support up to 128 Wi-Fi-enabled devices
- An RJ-11 port for optional Voice over LTE (VoLTE)
5G for private networks
According to IDC , the private LTE/5G equipment market will reach $5.7 Billion in 2024. “With more spectrum being made available for enterprise uses, coinciding with the arrival of commercial 5G, interest has grown toward using private LTE/5G solutions as a basis for connectivity across a multitude of mission-critical, industrial and traditional enterprise organizations.”
Inseego 5G: Fast, reliable and secure
Designed and developed in the U.S., Inseego 5G products deliver high speed and low latency with extensive cybersecurity, including WPA3 Wi-Fi security with advanced encryption, Open VPN, IPsec VPN, parental controls and more.
To learn more about Inseego 5G products and solutions go to inseego.com . For press and analyst inquires, please email press@inseego.com
* Pending carrier approval.
About Inseego Corp.
Inseego Corp. (Nasdaq: INSG) is an industry leader in smart device-to-cloud solutions that extend the 5G network edge, enabling broader 5G coverage, multi-gigabit data speeds, low latency and strong security to deliver highly reliable internet access. Our innovative mobile broadband, fixed wireless access (FWA) solutions, and software platform incorporate the most advanced technologies (including 5G, 4G LTE, Wi-Fi 6 and others) into a wide range of products that provide robust connectivity indoors, outdoors and in the harshest industrial environments.
Designed and developed in the USA, Inseego products and SaaS solutions build on the company’s patented technologies to provide the highest quality wireless connectivity for service providers, enterprises, and government entities worldwide. www.inseego.com #Putting5GtoWork
©2021 Inseego Corp. All rights reserved. The Inseego name and logo are registered trademarks, and the Wavemaker and Inseego Manage names are trademarks of Inseego Corp. Other Company, product or service names mentioned herein are the trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005447/en/
Link:
Social Media:
https://www.facebook.com/Inseego/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom